Compare HBB & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBB | LENZ |
|---|---|---|
| Founded | 1904 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 198.8M |
| IPO Year | 2017 | 2021 |
| Metric | HBB | LENZ |
|---|---|---|
| Price | $20.49 | $5.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 18.6K | ★ 614.9K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $606,852,000.00 | $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | $76.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.72 | $5.23 |
| 52 Week High | $21.84 | $50.19 |
| Indicator | HBB | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 31.78 |
| Support Level | $17.90 | N/A |
| Resistance Level | $21.84 | $10.42 |
| Average True Range (ATR) | 0.84 | 0.44 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 96.69 | 26.82 |
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products segment includes consumer product revenue consisting of sales of small electric household and specialty housewares appliances whereas the health segment includes lease revenue associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue which grant customers the right to use software for healthcare management.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.